Nelfone 250 Tablet contains Nelfinavir 250mg, a well-established antiretroviral protease inhibitor used in combination regimens for the treatment of HIV infection. It helps in suppressing viral replication and supports long-term immune system preservation in affected patients.
Nelfinavir works by inhibiting the HIV protease enzyme, preventing the maturation of infectious viral particles. This mechanism plays a critical role in reducing viral load, improving CD4 cell counts, and slowing disease progression when used as part of combination antiretroviral therapy.
For distributors and healthcare suppliers, Nelfone 250 Tablet is a specialty infectious disease product, supplied to ART centers, hospitals, and institutional healthcare programs. Ongoing demand for antiretroviral medicines ensures consistent requirement across public and private healthcare sectors.
Adding Nelfone 250 Tablet to your HIV and antiretroviral therapy segment creates strong opportunities in hospital supply, specialty pharmacies, export markets, and third-party manufacturing. Its established clinical role, protocol-based usage, and global demand make it a valuable product in pharmaceutical distribution portfolios.